We are delighted to present that Biocytogen will be attending the PBSS Predicting Human Pharmacokinetics and Doses of Diverse Modalities: The Current State of the Art and Case Studies Vendor show on October 2nd in East Cambridge, MA! Hear from top industry experts, multiple vendors and associations. Stop by our booth to learn more about Biocytogen’s advancements in life sciences, and meet our team. We hope to see you there!
What is PBSS Predicting Human Pharmacokinetics and Doses of Diverse Modalities: The Current State of the Art and Case Studies?
The PBSS Predicting Human Pharmacokinetics and Doses of Diverse Modalities: The Current State of the Art and Case Studies is a full-day program designed for formulation scientists, project leaders, and R&D professionals looking to elevate their drug development strategies. Join PBSS for in-depth, in-person workshops, panels and presentations on Small‑Molecule Formulation for Discovery & Early Development, and connect with expert scientists and professionals.
Event Overview
Date: October 2nd, 2025 | Time: 08:30 AM - 05:30 PM ET
Venue: Bristol Myers Squibb, 250 Water St, East Cambridge, MA 0214
Event Schedule
For a more in-depth overview of the agenda, please refer to PBSS schedule
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you in East Cambridge, MA!
